Experiment 361103

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismHypericum perforatum (CLUSIACEAE)
CitationWOELK,H: BURKARD,G: GRUNWALD,J:. (1994). BENEFITS AND RISK OF THE HYPERICUM EXTRACT LI 160: DRUG MONITORING STUDY WITH 3250 PATIENTS.. 7()
Amount utilized
Compound isolated
DiseaseEFFECTIVENESS AND ACCEPTANCE OF A 4-WEEK TREATMENT WITH HYPERICUM EXTRACT LI 160 WERE INVESTIGATED BY 663 PRIVATE PRACTITIONERS. THE RESULTS OF THE 3250 PATIENTS (76% WOMEN AND 24% MEN), WERE RECORDED USING DATA SHEETS. THE AGE OF THE PATIENTS RANGED FROM 20 TO 90 YEARS (MEAN 51 YEARS). OF THE PATIENTS, 49% WERE MILDLY DRPRESSED, 46% INTERMEDIATE, AND 3% SEVERELY DEPRESSED. IN ABOUT 30% OF THE PATIENTS, THE SITUATION NORMALIZED OR IMPROVED DURING THE THERAPY. UNDESIRED DRUG EFFECTS WERE REPORTED IN 79 (2.4%) PATIENTS AND 48 (1.5%) DISCONTINUED THE THERAPY. MOST FREQUENTLY NOTED SIDE EFFECTS WERE GASTROINTESTINAL IRRITATIONS (0.6%), ALLERGIC REACTIONS (0.5%), TIREDNESS (0.4%), AND RESTLESSNESS (0.3%).
Dose amount900.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractAERIAL PARTS
GenderGIVEN TO BOTH SEXES